PDPL

Parenteral Drugs (India) Limited has informed the Exchange about Board Meeting held on 30-May-2022 to consider financial statements for the period ended March 2022 and Other business matters

Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Board meeting held on February 14, 2022.

Parenteral Drugs (India) Limited has informed the Exchange regarding outcome of the Board meeting held on February 02, 2022.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on November 12, 2021 for approval of Quarterly Unaudited Financial Results ( on both Standalone and Consolidated basis) of the company for the financial year 2021-22 ended on 30th September,2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on August 26, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on August 10, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on Jun 30, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on February 12, 2021.

Parenteral Drugs (India) Limited has informed the Exchange regarding outcome of Board meeting held on November 10, 2020

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on August 25, 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on July 29, 2020.

Parenteral Drugs (India) Limited hereby submits Outcome of Board meeting held on February 12, 2020.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on November 13, 2019.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on August 05, 2019.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on May 30, 2019.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on February 14, 2019 in which Board inter alia considered and approved the Unaudited Financial Results (both Standalone and Consolidated) of the company for the third quarter of the financial year 2018-19 ended on 31st December, 2018.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on November 13, 2018.

Parenteral Drugs (India) Limited has informed the Exchange regarding Board meeting held on August 14, 2018.

Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on December 22, 2017.

Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Board Meeting of the Company held on February 13, 2017.

Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome Board Meeting held on October 21, 2016.

Parenteral Drugs (India) Limited has informed the Exchange that a meeting of the Board of Directors of the company was held on December 30, 2015 at the Corporate Office of the Company at Indore. The Board inter-alia considered and approved the disinvestment of equity shares held by the Company in its non-operational Subsidiary Companies i.e. Parentech Healthcare Limited and Parenteral Surgicals Limited as the same are loss making companies, and accorded its in-principle approval to declare the non-working Subsidiaries of the company i.e. Abhay Drugs Limited, Anjaney Pharmaceuticals Limited, Pa

Parenteral Drugs (India) Limited has informed the Exchange that A meeting of the Board of Directors of the company was held on September 30, 2015 at the Corporate Office of the Company at Indore. The Board inter-alia considered and approved the allotment of 0% Non-cumulative, Non-convertible, Redeemable Preference Shares of the Company.

Parenteral Drugs (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on July 18, 2015.

Parenteral Drugs (India) Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 30, 2015, approved the Code of Conduct of the company for the Board of Directors and the Designated persons of the company. The Company made provisions for writing off the amount invested in two foreign subsidiaries viz. Mascareignes Pharmaceuticals Manufacturing Limited, Mauritius and Parenteral Drugs Kazakhstan, Kazakhstan.

Parenteral Drugs (India) Limited has informed the Exchange that the meeting of the Board of Directors of the Company held on March 30, 2015 considered & approved inter-alia appointment of Ms. Deepali Garhewal as an additional and Independent director on the Board of the Company and relocation of the Indore plant of the Company situated at Village Asrawad, Post Dhudhia, Nemawar Road, Indore (Madhya Pradesh) to Village Panwa, Tehsil Kasrawad, District Khargone, Madhya Pradesh.

Parenteral Drugs (India) Limited has informed the Exchange that Board of Directors of the Company at its meeting held on October 30, 2013 has issued and allotted 39,49,469 Fully Paid-up Equity Shares to M/s. MVG Mercantile Private Limited, a Company under promoter category, pursuant to conversion of 29,62,102, 0% Optionally Convertible Redeemable Preference Shares.